Formulations comprising antisense nucleotides to connexins
CA 2730386 C · Owner: Becker, David L. · Inventors: Green, Colin R.; Becker, David L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression particularly in reduction of neuronal cells death wound healing, reduction of inflammation decrease of scar formation and skin rejuvenation and thickening.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 27, 2000 and granted August 11, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.